Axol: making your models more human
We give you access to more human in vitro models of physiology and disease through cells derived from human induced pluripotent stem cells (iPSCs). Research needs physiologically relevant, robust, and reliable models. We believe human iPSCs deliver exactly that.
Our focus is on providing you with excitable cells. This means:
- CiPA-validated cardiomyocytes for in vitro cardiotoxicity screening
- Central nervous system cells for cell-based models of neurodegenerative diseases
- Sensory neurons for models of pain and sensory neuron conditions
We research, develop and manufacture at our sites in Roslin and Cambridge UK.